drugset / Trial / NCT00002647

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

NCT00002647

Phase 1 Unknown 24 enrolled Medical College of Wisconsin
Treatment

Summary

RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and may be an effective treatment for refractory brain tumors. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy using porfimer sodium in treating patients with refractory brain tumors, including astrocytoma, ependymoma, and medulloblastoma.

Timeline

Start
1994-05
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Verteporfin Other / unclassified